NUV | VFL | NUV / VFL | |
Gain YTD | 2.068 | -3.166 | -65% |
Net Assets | 1.83B | 128M | 1,430% |
Total Expense Ratio | 0.47 | 1.01 | 47% |
Turnover | 21.00 | 72.00 | 29% |
Yield | 4.22 | 5.39 | 78% |
Fund Existence | 38 years | 32 years | - |
NUV | VFL | |
---|---|---|
RSI ODDS (%) | 3 days ago70% | 3 days ago84% |
Stochastic ODDS (%) | 3 days ago82% | 3 days ago71% |
Momentum ODDS (%) | 3 days ago69% | 3 days ago65% |
MACD ODDS (%) | 3 days ago76% | 3 days ago68% |
TrendWeek ODDS (%) | 3 days ago70% | 3 days ago76% |
TrendMonth ODDS (%) | 3 days ago74% | 3 days ago74% |
Advances ODDS (%) | 3 days ago76% | 26 days ago79% |
Declines ODDS (%) | 5 days ago76% | 7 days ago76% |
BollingerBands ODDS (%) | 3 days ago83% | 3 days ago47% |
Aroon ODDS (%) | 3 days ago70% | 3 days ago72% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ASVIX | 10.10 | 0.06 | +0.60% |
American Century Small Cap Value Inv | |||
VITSX | 152.68 | 0.67 | +0.44% |
Vanguard Total Stock Market Idx I | |||
GCLLX | 17.21 | 0.06 | +0.35% |
Goldman Sachs Enhanced U.S. Equity C | |||
VECRX | 22.33 | 0.07 | +0.31% |
Virtus KAR Equity Income R6 | |||
FBTTX | 25.58 | N/A | N/A |
Fidelity Advisor Biotechnology M |